Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Metastasis is responsible for 90% of cancer-related deaths. Strategies are needed that can inhibit the capacity of cancer cells to migrate across the anatomic barriers and colonize distant organs. Here, we show an association between metastasis and expression of a type I receptor tyrosine kinase–like orphan receptor, ROR1, which is expressed during embryogenesis and by various cancers, but not by normal postpartum tissues. We found that expression of ROR1 associates with the epithelial–mesenchymal transition (EMT), which occurs during embryogenesis and cancer metastasis. Breast adenocarcinomas expressing high levels of ROR1 were more likely to have gene expression signatures associated with EMT and had higher rates of relapse and metastasis than breast adenocarcinomas expressing low levels of ROR1. Suppressing expression of ROR1 in metastasis-prone breast cancer cell lines, MDA-MB-231, HS-578T, or BT549, attenuated expression of proteins associated with EMT (e.g., vimentin, SNAIL-1/2, and ZEB1), enhanced expression of E-cadherin, epithelial cytokeratins (e.g., CK-19), and tight junction proteins (e.g., ZO-1), and impaired their migration/invasion capacity in vitro and the metastatic potential of MDA-MB-231 cells in immunodeficient mice. Conversely, transfection of MCF-7 cells to express ROR1 reduced expression of E-cadherin and CK-19, but enhanced the expression of SNAIL-1/2 and vimentin. Treatment of MDA-MB-231 with a monoclonal antibody specific for ROR1 induced downmodulation of vimentin and inhibited cancer cell migration and invasion in vitro and tumor metastasis in vivo. Collectively, this study indicates that ROR1 may regulate EMT and metastasis and that antibodies targeting ROR1 can inhibit cancer progression and metastasis. Cancer Res; 73(12); 3649–60. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Zhang et al. conducted the third-generation CAR-T cells targeting B7-H3 and proved the killing effects for tumor cells in vitro and in vivo using the patientderived xenografts (PDXs) model of osteosarcoma [116–125].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [125]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They utilize humanized anti-receptor tyrosine kinase-like orphan receptor 1 (αROR1, clone: 2A2) antibodies as the additional ligand, specifically targeting ROR1 receptors, which are typically found on tumors but absent in normal tissues [139, 140].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [140]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Overexpression of tyrosine kinase-like orphan receptor 1 (ROR1) involved in tumor cell migration and invasiveness [125].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“Through use of multiple pathways involved in embryonic morphogenesis and wound healing, cancer cells also can concomitantly acquire attributes that enable invasion and metastasis (10).”
BackgroundThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 1×
“EMT is required for normal development (7, 10); during early embryogenesis, epithelial cells undergo this transition, allowing them to lose cell-cell contact and cell polarity, acquire gene-expression signatures of mesenchymal cells, and develop the increased motility and invasiveness required to seed developing organ…”
BackgroundEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 2×
“has focused on a cell-biological program called epithelial-mesenchymal transition (EMT), which is thought to factor prominently in tumor self-renewal, progression, and metastasis (1, 4, 7, 8).”
BackgroundThe Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 1×
“Some studies have found non-CSCs can become CSC-like cells upon acquiring characteristics of cells in EMT (11, 12)_ENREF_10.”
BackgroundA Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807 · cited 4×
“Furthermore, work to define cancer stem cells (CSCs), which may account for relapse after therapy, has identified a variety of traits that are associated with one or more subpopulations of CSCs _ENREF_10 within various tumors (1, 4).”
BackgroundInfluentialTumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011 · cited 1×
“Metastasis is responsible for 90% of cancer-related deaths (1, 2).”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“Breast-cancer cell lines MDA-MB-231, HS-578T, BT549, MDA-MB-435s, MDA-MB-436, MDA-MB-157, MDA-MB-134, MCF7, BT-474, MDA-MB-453, SKBR3, MDA-MB-330, BT-483 and T47D were obtained from the ATCC (Manassas, VA) and maintained as described (28).”
MethodMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649 · cited 3×
“This process includes the physical translocation of primary tumor cells across anatomic barriers to distant organs with subsequent colonization (1, 3, 4).”
BackgroundEMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · cited 1×
“As such, cancer cells that undergo EMT may exhibit a CSC phenotype and acquire invasive properties that promote extravasation, angiogenesis, self-renewal, and uncontrolled growth at metastatic sites (3, 4, 13).”
Background
Cited by
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xu, X., Zhang, M., Xu, F., & Jiang, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01276-5 · Cited by 588
Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225758 · Cited by 605
“Previous studies reported that ROR1 functions as a regulator of EMT-related genes and highly expressed ROR1 exhibited a positive correlation to the malignancy attributes of CRC patients [110,111].”
BackgroundGlucocorticoids promote breast cancer metastasis
Obradović, M. M. S., Hamelin, B., Manevski, N., Couto, J. P., Sethi, A., Coissieux, M.-M., Münst, S., Okamoto, R., Kohler, H., Schmidt, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1019-4 · Cited by 462
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
Marcucci, F., Stassi, G., & De Maria, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.13 · Cited by 342
Wnt signaling in triple-negative breast cancer
Pohl, S.-G., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.14 · Cited by 296
Metadata
- Authors
- Cui, B., Zhang, S., Chen, L., Yu, J., Widhopf, G. F., Fecteau, J.-F., Rassenti, L. Z., & Kipps, T. J.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Kipps, Thomas J.
- Venue
- Cancer Research
- Published
- 2013-06-13
- Volume
- 73
- Issue
- 12
- Pages
- 3649-3660
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC3832210
- OpenAlex
- W1983054966
- Cited by
- 187
- References
- 52
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 30 · 2023: 17 · 2022: 12 · 2021: 12 · 2020: 9 · 2019: 22 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 12 · 2014: 9 · 2013: 3
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (4p01ca081534-16)
- National Cancer Institute (P01-CA-081534)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- ROR1, epithelial-mesenchymal transition, metastasis, breast adenocarcinoma, receptor tyrosine kinase-like orphan receptor, monoclonal antibodies, vimentin, ZEB1, E-cadherin, cytokeratin, tight junction proteins, cell migration and invasion, tumor recurrence
- MeSH terms
- Animals, Antibodies, Monoclonal, Breast Neoplasms, Cell Movement, Female, Humans, Mammary Neoplasms, Experimental, Neoplasm Metastasis, Prognosis, Transplantation, Heterologous, Immunoblotting, Gene Expression Regulation, Neoplastic, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, RNA Interference, Cell Line, Tumor, Mice, Kaplan-Meier Estimate, Receptor Tyrosine Kinase-like Orphan Receptors, Epithelial-Mesenchymal Transition, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-3832
- The paper
- Cui, B., Zhang, S., Chen, L., Yu, J., Widhopf, G. F., Fecteau, J.-F., Rassenti, L. Z., & Kipps, T. J. (2013). Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-3832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.